Lesley Seymour

12PUBLICATIONS
143CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Jun 01, 2026
Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global Implementation.

|Jan 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials.

Jia Liu, Max Farrow, Lesley Seymour

|Nov 08, 2024
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.

Eric Winquist, Sebastien J Hotte, Kim Chi

|Sep 13, 2024
Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group.

Alexander W Wyatt, Saskia Litiere, Francois-Clément Bidard

|Apr 18, 2024
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group.

Erica C Nakajima, Amber Simpson, Jan Bogaerts

Pageof 2

Frequent Collaborators

4 joint publications

Elena Garralda

3 joint publications

Alexander W Wyatt

3 joint publications

S Percy Ivy

3 joint publications

Elisabeth G E deVries